Literature DB >> 6416509

Should patients with renal failure associated with myeloma be dialysed?

R A Coward, N P Mallick, I W Delamore.   

Abstract

In a study of renal function in multiple myeloma seven patients presented with renal failure and three developed it 16-106 months after diagnosis. All were dialysed. Infection with dehydration was a precipitating factor in all seven cases of acute or acute on chronic renal failure. Of these, two patients recovered normal renal function and one other was left with permanent renal impairment but no longer required dialysis. Results from the seven patients with acute renal failure and for the three with more chronic features support the practice of dialysis for all patients who present with renal failure. Dialysis is not indicated for those patients with progressive myelomatous disease. The study showed no evidence that chemotherapy permitted recovery from established renal failure. The prognosis in this elderly group is heavily dependent on the presence of cardiovascular or other degenerative disease.

Entities:  

Mesh:

Year:  1983        PMID: 6416509      PMCID: PMC1549805          DOI: 10.1136/bmj.287.6405.1575

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Acute renal failure in multiple myeloma.

Authors:  R A Defronzo; R L Humphrey; J R Wright; C R Cooke
Journal:  Medicine (Baltimore)       Date:  1975-05       Impact factor: 1.889

2.  Effects on rat kidney slice function in vitro of proteins from the urines of patients with myelomatosis and nephrosis.

Authors:  H G Preuss; F R Weiss; R M Iammarino; W J Hammack; H V Murdaugh
Journal:  Clin Sci Mol Med       Date:  1974-03

3.  Immunofluorescent studies of the myeloma kidney with special reference to light chain disease.

Authors:  D F Levi; R C Williams; F D Lindstrom
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

4.  Effect of sustained diuresis on the renal lesions of mice with Bence Jones protein-producing tumors.

Authors:  C W Bryan; K R McIntire
Journal:  J Lab Clin Med       Date:  1974-03

5.  Inflammation and haemostasis in paraproteinaemias.

Authors:  R Penny; P A Castaldi; H M Whitsed
Journal:  Br J Haematol       Date:  1971-01       Impact factor: 6.998

6.  Acute renal failure after excretory urography in multiple myeloma.

Authors:  G H Myers; D M Witten
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1971-11

7.  Radioimmunoassay of free light chains of immunoglobulins in urine.

Authors:  E L Robinson; E Gowland; I D Ward; J H Scarffe
Journal:  Clin Chem       Date:  1982-11       Impact factor: 8.327

8.  Multiple myeloma: review of 869 cases.

Authors:  R A Kyle
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

9.  Steroid pulses and plasmapheresis in the treatment of acute renal failure in multiple myeloma.

Authors:  F Locatelli; C Pozzi; L Pedrini; P Marai; S Di Filippo; R Ponti; R Costanzo
Journal:  Proc Eur Dial Transplant Assoc       Date:  1980

10.  Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyanin.

Authors:  J Harris; R Alexanian; E Hersh; P Migliore
Journal:  Can Med Assoc J       Date:  1971-03-06       Impact factor: 8.262

View more
  6 in total

1.  The kidney in myeloma.

Authors:  T J Hamblin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

2.  The kidney in myeloma.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-01

3.  Dialysis treatment in multiple myeloma.

Authors:  I Taraba; A Hering
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

4.  The cost of chronic dialysis in multiple myeloma.

Authors:  R A Coward
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

5.  Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Authors:  J H Brown; A P Maxwell; I Bruce; B G Murphy; C C Doherty
Journal:  Ir J Med Sci       Date:  1993-06       Impact factor: 1.568

Review 6.  Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Authors:  J H Brown; C C Doherty
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.